An international team of scientists has unveiled the most comprehensive model yet that explains how cells control the flow of ...

Understanding molecular diversity is fundamental to biomedical research and diagnostics, but existing analytical tools ...

New research suggests a missing brain molecule may hold the key to understanding—and potentially treating—the faulty neural ...

For decades, world leaders, regulators, and corporate executives have gathered in hotel ballrooms and convention centers to ...

Michael Gotthardt at the Max Delbrück Center and collaborators are developing a drug to treat a common type of heart failure ...

Cidara’s lead candidate, CD388, is a long-acting antiviral prophylactic designed for universal prevention of seasonal and ...

EKZ-102, an experimental oral therapy for amyotrophic lateral sclerosis (ALS), is on track to enter early clinical testing in ...

Every so often, an idea stops belonging to one company and starts belonging to the world. Proof is that idea - and SMX ...

The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds-those with high potency, selectivity, and favorable metabolic properties-at the earliest stages ...

The pH, or the acidity or alkalinity of an environment, has long been known to affect how efficiently catalysts drive key ...

As sunlight filters through your window each morning, a quiet, powerful rhythm pulses inside your body. This inner clock ...

Faulty brain circuits seen in Down syndrome may be caused by the lack of a particular molecule essential for the development and function of the ...